Ambu A/S (OTCMKTS:AMBBY) Short Interest Down 50.0% in December

Ambu A/S (OTCMKTS:AMBBYGet Free Report) was the recipient of a large drop in short interest in the month of December. As of December 15th, there was short interest totalling 100 shares, a drop of 50.0% from the November 30th total of 200 shares. Based on an average trading volume of 400 shares, the days-to-cover ratio is presently 0.3 days.

Ambu A/S Stock Performance

Shares of OTCMKTS:AMBBY remained flat at $13.02 on Friday. The stock had a trading volume of 10 shares, compared to its average volume of 678. The company’s 50 day moving average price is $16.31 and its 200-day moving average price is $18.52. Ambu A/S has a 12 month low of $13.02 and a 12 month high of $22.65. The company has a quick ratio of 1.47, a current ratio of 2.49 and a debt-to-equity ratio of 0.09. The firm has a market capitalization of $3.06 billion and a P/E ratio of 108.50.

Ambu A/S Announces Dividend

The company also recently declared a dividend, which was paid on Monday, December 23rd. Investors of record on Friday, December 6th were paid a dividend of $0.0557 per share. The ex-dividend date of this dividend was Friday, December 6th. Ambu A/S’s dividend payout ratio is 16.67%.

Ambu A/S Company Profile

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

See Also

Receive News & Ratings for Ambu A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambu A/S and related companies with MarketBeat.com's FREE daily email newsletter.